Literature DB >> 29466332

Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex.

Yi-Lynn Liang1, Maryam Khoshouei2, Alisa Glukhova1, Sebastian G B Furness1, Peishen Zhao1, Lachlan Clydesdale1, Cassandra Koole1, Tin T Truong1, David M Thal1, Saifei Lei3,4, Mazdak Radjainia1,5, Radostin Danev2, Wolfgang Baumeister2, Ming-Wei Wang3,4,6, Laurence J Miller1,7, Arthur Christopoulos1, Patrick M Sexton1,6, Denise Wootten1.   

Abstract

The class B glucagon-like peptide-1 (GLP-1) G protein-coupled receptor is a major target for the treatment of type 2 diabetes and obesity. Endogenous and mimetic GLP-1 peptides exhibit biased agonism-a difference in functional selectivity-that may provide improved therapeutic outcomes. Here we describe the structure of the human GLP-1 receptor in complex with the G protein-biased peptide exendin-P5 and a Gαs heterotrimer, determined at a global resolution of 3.3 Å. At the extracellular surface, the organization of extracellular loop 3 and proximal transmembrane segments differs between our exendin-P5-bound structure and previous GLP-1-bound GLP-1 receptor structure. At the intracellular face, there was a six-degree difference in the angle of the Gαs-α5 helix engagement between structures, which was propagated across the G protein heterotrimer. In addition, the structures differed in the rate and extent of conformational reorganization of the Gαs protein. Our structure provides insights into the molecular basis of biased agonism.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29466332     DOI: 10.1038/nature25773

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  44 in total

1.  The G226A mutant of Gs alpha highlights the requirement for dissociation of G protein subunits.

Authors:  E Lee; R Taussig; A G Gilman
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

2.  The N54 mutant of Galphas has a conditional dominant negative phenotype which suppresses hormone-stimulated but not basal cAMP levels.

Authors:  J H Cleator; N D Mehta; D T Kurtz; J D Hildebrandt
Journal:  FEBS Lett       Date:  1999-01-25       Impact factor: 4.124

3.  Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.

Authors:  K Coopman; R Wallis; G Robb; A J H Brown; G F Wilkinson; D Timms; G B Willars
Journal:  Mol Endocrinol       Date:  2011-08-25

4.  Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1.

Authors:  Marlies V Hager; Lachlan Clydesdale; Samuel H Gellman; Patrick M Sexton; Denise Wootten
Journal:  Biochem Pharmacol       Date:  2017-03-29       Impact factor: 5.858

5.  Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Celine Valant; Rohan Sridhar; Owen L Woodman; Laurence J Miller; Roger J Summers; Arthur Christopoulos; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2010-06-14       Impact factor: 4.436

6.  Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands.

Authors:  Denise Wootten; Emilia E Savage; Francis S Willard; Ana B Bueno; Kyle W Sloop; Arthur Christopoulos; Patrick M Sexton
Journal:  Mol Pharmacol       Date:  2013-01-24       Impact factor: 4.436

Review 7.  Peptide binding at the GLP-1 receptor.

Authors:  R Mann; N Nasr; D Hadden; J Sinfield; F Abidi; S Al-Sabah; R López de Maturana; J Treece-Birch; A Willshaw; D Donnelly
Journal:  Biochem Soc Trans       Date:  2007-08       Impact factor: 5.407

8.  The Extracellular Surface of the GLP-1 Receptor Is a Molecular Trigger for Biased Agonism.

Authors:  Denise Wootten; Christopher A Reynolds; Kevin J Smith; Juan C Mobarec; Cassandra Koole; Emilia E Savage; Kavita Pabreja; John Simms; Rohan Sridhar; Sebastian G B Furness; Mengjie Liu; Philip E Thompson; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  Cell       Date:  2016-06-16       Impact factor: 41.582

9.  Volta phase plate cryo-EM of the small protein complex Prx3.

Authors:  Maryam Khoshouei; Mazdak Radjainia; Amy J Phillips; Juliet A Gerrard; Alok K Mitra; Jürgen M Plitzko; Wolfgang Baumeister; Radostin Danev
Journal:  Nat Commun       Date:  2016-01-28       Impact factor: 14.919

10.  The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling.

Authors:  Rachel L Dods; Dan Donnelly
Journal:  Biosci Rep       Date:  2015-11-23       Impact factor: 3.840

View more
  93 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors.

Authors:  Madhu Chaturvedi; Justin Schilling; Alexandre Beautrait; Michel Bouvier; Jeffrey L Benovic; Arun K Shukla
Journal:  Trends Biochem Sci       Date:  2018-05-04       Impact factor: 13.807

3.  Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.

Authors:  Oleg G Chepurny; Minos-Timotheos Matsoukas; George Liapakis; Colin A Leech; Brandon T Milliken; Robert P Doyle; George G Holz
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

4.  Biochemical Characterization of GPCR-G Protein Complex Formation.

Authors:  Filip Pamula; Ching-Ju Tsai
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Cryo-EM in drug discovery: achievements, limitations and prospects.

Authors:  Jean-Paul Renaud; Ashwin Chari; Claudio Ciferri; Wen-Ti Liu; Hervé-William Rémigy; Holger Stark; Christian Wiesmann
Journal:  Nat Rev Drug Discov       Date:  2018-06-08       Impact factor: 84.694

Review 6.  Structural biology of G protein-coupled receptor signaling complexes.

Authors:  X Edward Zhou; Karsten Melcher; H Eric Xu
Journal:  Protein Sci       Date:  2018-12-13       Impact factor: 6.725

Review 7.  Biosynthesis and Chemical Applications of Thioamides.

Authors:  Nilkamal Mahanta; D Miklos Szantai-Kis; E James Petersson; Douglas A Mitchell
Journal:  ACS Chem Biol       Date:  2019-01-30       Impact factor: 5.100

8.  Molecular Mechanisms of Class B GPCR Activation: Insights from Adrenomedullin Receptors.

Authors:  Michael L Garelja; Maggie Au; Margaret A Brimble; Joseph J Gingell; Erica R Hendrikse; Annie Lovell; Nicole Prodan; Patrick M Sexton; Andrew Siow; Christopher S Walker; Harriet A Watkins; Geoffrey M Williams; Denise Wootten; Sung H Yang; Paul W R Harris; Debbie L Hay
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-26

9.  Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins.

Authors:  Yi-Lynn Liang; Matthew J Belousoff; Madeleine M Fletcher; Xin Zhang; Maryam Khoshouei; Giuseppe Deganutti; Cassandra Koole; Sebastian G B Furness; Laurence J Miller; Debbie L Hay; Arthur Christopoulos; Christopher A Reynolds; Radostin Danev; Denise Wootten; Patrick M Sexton
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-20

Review 10.  Structural biology of G protein-coupled receptors: new opportunities from XFELs and cryoEM.

Authors:  Andrii Ishchenko; Cornelius Gati; Vadim Cherezov
Journal:  Curr Opin Struct Biol       Date:  2018-03-16       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.